Indian origin researcher Tejoram Vivekanandan and his team at the University of Washington (UW) have clinched the top prize at the 2025 Hollomon Health Innovation Challenge (HIC), impressing judges with their AI-powered newborn health monitoring system.
Luminovah, the startup led by Vivekanandan, Lillian Tran, and Nana Wang, was awarded the $15,000 Hollomon Family Grand Prize for its non-invasive technology aimed at reducing jaundice-related neonatal deaths.
"Newborn jaundice remains the fourth-largest cause of neonatal mortality," the team stated in their pitch. "We believe Luminovah can significantly improve early detection and treatment, potentially saving thousands of lives worldwide."
Luminovah also took home the $2,500 Naturacur Wound Healing Best Idea for a Medical Device award. The prize recognizes medical device concepts with the most promising potential to enhance patient care. The competition, hosted by the Buerk Center for Entrepreneurship at UW’s Foster School of Business, showcased the ingenuity of student-led teams tackling pressing healthcare challenges.
The team’s success builds on previous achievements, including securing $25,000 in funding from the UW CoMotion Innovation Gap Fund. Notably, Luminovah is the first prize-winning team to include a cohort member from the Women's Entrepreneurial Leadership Program (WE Lead).
Vivekanandan, whose background spans research stints at ISRO in 2019 and NASA in 2020, previously worked as a research assistant in the Computational Imaging Lab at IIM Madras, India. He completed his bachelor's degree at Coimbatore Institute of Technology in India before joining UW.
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login